CYP2J12 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the CYP2J12 enzyme, a member of the cytochrome P450 superfamily. The CYP2J12 enzyme is involved in the metabolism of a variety of substrates, including endogenous molecules such as fatty acids, eicosanoids, and other bioactive lipids, as well as exogenous compounds like certain drugs and environmental toxins. This enzyme plays a critical role in the oxidative metabolism of these substrates, catalyzing reactions that incorporate an oxygen atom into the substrate. These oxidative modifications are essential for transforming lipophilic molecules into more hydrophilic forms, thereby facilitating their further metabolism, conjugation, or excretion. The activity of CYP2J12 is particularly significant in tissues such as the liver, heart, and kidneys, where it contributes to the regulation of lipid signaling pathways and the detoxification of potentially harmful compounds.
Inhibitors of CYP2J12 are typically small molecules that interact directly with the enzyme's active site, blocking its ability to bind and oxidize its natural substrates. These inhibitors may function by occupying the substrate-binding pocket, preventing substrates from accessing the catalytic site, or by inducing conformational changes that decrease the enzyme's catalytic efficiency. The design and development of CYP2J12 inhibitors involve detailed structural analysis of the enzyme to identify critical regions involved in substrate recognition and catalysis. By inhibiting CYP2J12, researchers can explore the enzyme's specific role in lipid metabolism and other related pathways, gaining insights into how the modulation of this enzyme affects broader metabolic networks. The study of CYP2J12 inhibitors is crucial for understanding the enzyme's substrate specificity, its interactions with other metabolic enzymes, and its overall contribution to maintaining metabolic homeostasis within the body. This research deepens our understanding of the functional roles of cytochrome P450 enzymes, emphasizing their importance in the metabolism and regulation of bioactive lipids and other essential compounds in biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1-Aminobenzotriazole | 1614-12-6 | sc-200600 sc-200600A | 50 mg 100 mg | $61.00 $134.00 | 6 | |
A potent suicide inhibitor of cytochrome P450 enzymes. It irreversibly binds to the heme group, inhibiting the enzymatic activity involved in the epoxygenase P450 pathway and xenobiotic metabolism. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
An imidazole antifungal compound that acts as a potent inhibitor of CYP2J2. It interferes with the monooxygenase activity, impacting the linoleic acid metabolic process and leading to indirect inhibition of the target protein. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Broad-spectrum antifungal agent and a potent inhibitor of CYP2J2. It hinders the isomerase activity and influences the xenobiotic metabolic process, contributing to the inhibition of the target protein in intracellular membrane-bounded organelles. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Azole antifungal with inhibitory effects on CYP2J2. It disrupts the isomerase activity, affecting the linoleic acid metabolic process and contributing to indirect inhibition of the target protein in the cytoplasm. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
An imidazole antifungal with CYP2J2 inhibitory properties. It interferes with the monooxygenase activity, impacting the xenobiotic metabolic process, leading to indirect inhibition of the target protein in intracellular membrane-bounded organelles. | ||||||
Econazole | 27220-47-9 | sc-279013 | 5 g | $240.00 | ||
Imidazole antifungal agent known for inhibiting CYP2J2. It interferes with the monooxygenase activity, impacting the xenobiotic metabolic process and contributing to indirect inhibition of the target protein in the cytoplasm. | ||||||
Ticlopidine Hydrochloride | 53885-35-1 | sc-205861 sc-205861A | 1 g 5 g | $32.00 $99.00 | 2 | |
An antiplatelet drug acting as a CYP2J2 inhibitor. It influences the isomerase activity, affecting the xenobiotic metabolic process and contributing to indirect inhibition of the target protein in intracellular membrane-bounded organelles. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Selective serotonin reuptake inhibitor with inhibitory effects on CYP2J2. It disrupts the isomerase activity, impacting the xenobiotic metabolic process, leading to indirect inhibition of the target protein in the cytoplasm. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Antifungal agent in research known to inhibit CYP2J2. It interferes with the monooxygenase activity, impacting the xenobiotic metabolic process and contributing to indirect inhibition of the target protein in intracellular membrane-bounded organelles. | ||||||